Blinding at the Bedside

Part of Research Nurse (RN) Training: Study Intervention Administration.

About 2 minutes. Free, in your language, no account needed.

Why this matters

A blind is easy to describe and easy to break. Most breaks are accidental, and most happen at the bedside rather than in a database.

Once a participant or an assessor knows the arm, that knowledge cannot be removed. It changes what people report and what assessors record, often without anyone intending it.

How blinds break in a clinic

Appearance. Active drug and placebo that look, smell or feel different.

Handling. An unblinded pharmacist preparing a dose in view of blinded staff.

Conversation. A nurse saying "you are definitely on the real thing" as encouragement.

Documents. An unblinded lab result filed where blinded staff read it.

Side effects. Sometimes unavoidable, but discussing them as evidence of arm is not.

Who is blinded, and who is not

Most trials have some unblinded staff, usually in pharmacy. Know which category you are in, and know who else is in each.

If you are blinded, you do not look at anything that would unblind you, even when it is easy to. Curiosity satisfied once is a break that lasts for the rest of the study.

Protecting a participant's blind

Participants will ask you which arm they are on. They will also guess aloud and watch your face.

Answer the same way every time, for everyone. That you do not know, that nobody at the site is meant to know, and that this is what makes the result trustworthy.

A neutral answer given consistently protects the blind better than any procedure.

In practice

A participant says they are sure they are on placebo because they feel nothing.

You do not reassure them that plenty of people on active drug feel nothing. That is a hint, however kindly meant. You say that you cannot know, that feeling nothing is common in both arms, and you record the comment if the protocol asks you to.

What this looks like when it goes wrong

An unblinded pharmacy technician mentions, helpfully, that a participant's kit is "one of the real ones" while handing it over at the nurses' station.

Two blinded nurses hear it. Every subsequent assessment those nurses perform on that participant is now made by someone who knows the arm.

The site must report it, and the sponsor must decide whether that participant's endpoint data can still be used.

Key takeaways